Skip to main content
. 2017 Jun 13;9(5):403–409. doi: 10.4168/aair.2017.9.5.403

Table 1. AR subgroups according to nasal cytology.

Characteristics AR(Eos) AR(Eos/Neu) AR(Neu) AR(Low)
No. (%) 224/468 (47.86) 112/468 (23.93) 67/468 (14.32) 65/468 (13.89)
Gender (male) 132 (58.93) 70 (62.50) 49 (73.13) 34 (52.31)
Age (year) 18.76±14.60 15.64±14.23 15.06±14.03 18.59±12.39
History (year) 3.24±2.95 3.21±2.30 2.95±2.54 3.86±2.40
Asthma 24 (10.71) 10 (8.93) 6 (8.96) 4 (6.15)
VAS 61.85±20.56 59.38±22.23 56.73±23.66 55.25±22.03
Nasal blockage 1.99±0.79* 1.71±1.00 1.50±0.80 1.60±0.68
Nasal itching 1.53±0.77 1.42±0.58 1.50±0.74 1.65±0.59
Nasal secretion 1.70±0.76 1.79±0.51 1.73±0.77 1.75±0.79
Sneezing 1.77±0.61 1.63±0.71 1.59±0.73 1.60±0.88
Total score 6.99±1.92 6.54±2.21 6.32±2.42 6.60±1.93
Eos % 86.70±15.00 28.77±11.61 4.00±4.17 -
Neu % 13.30±15.00 71.23±11.61 96.00±4.17 -
Inflammatory cell grade and distribution 2.85±0.52
(grade 2: 49, grade 3: 159, grade 4: 16)
2.79±0.54
(grade 2: 31, grade 3: 74, grade 4: 7)
3.20±0.59
(grade 2: 6, grade 3: 41, grade 4: 20)
-
(grade 0: 5, grade 1: 60)

Data are shown as mean±SD or number (%).

AR, allergic rhinitis; VAS, visual analog scale; SD, standard deviation.

*Compared to AR(Neu), P=0.02; †Compared to AR(Eos) and AR(Eos/Neu), P<0.01.